BRIEF published on 03/18/2026 at 18:05, 7 months 18 days ago Amoéba publie le document d'enregistrement universel 2025 Ingrédient Cosmétique Document D'Enregistrement Universel Approbation Réglementaire Rapport Financier 2025 Marché De La Biocontrôle
BRIEF published on 03/18/2026 at 18:05, 7 months 18 days ago Performance financière 2025 d'Aubay : une année record Chiffre D'affaires Marge Opérationnelle Dividende Résultat Net Résultats 2025
BRIEF published on 03/18/2026 at 18:05, 7 months 18 days ago Aubay Reports Record 2025 Financial Results Revenue Growth Dividend Proposal Record Financial Results 2026 Outlook Strategic Adaptability
BRIEF published on 03/18/2026 at 18:05, 7 months 18 days ago SIRIUS MEDIA : Nouveaux accords de distribution pour ses séries phares SIRIUS MEDIA Production Audiovisuelle Nouveaux Accords Séries Internationales Distribution Élargie
BRIEF published on 03/18/2026 at 18:05, 7 months 18 days ago Aubay's 2025 financial performance: a record year Revenue Dividend Net Result Operating Margin 2025 Results
BRIEF published on 03/18/2026 at 18:05, 7 months 18 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities Transparence Financière Pharmaceutique Atlas Special Opportunities Investissements Digitaux Oxurion
BRIEF published on 03/18/2026 at 18:05, 7 months 18 days ago Aubay annonce des résultats financiers records pour 2025 Croissance Des Revenus Proposition De Dividende Résultats Financiers Records Perspectives Pour 2026 Adaptabilité Stratégique
BRIEF published on 03/18/2026 at 18:05, 7 months 18 days ago SIRIUS MEDIA: New distribution agreements for its flagship series SIRIUS MEDIA Audiovisual Production New Agreements International Series Wider Distribution
BRIEF published on 03/18/2026 at 18:05, 7 months 18 days ago Oxurion Acknowledges Transparency Notification from Atlas Pharmaceuticals Transparency Oxurion Belgian Legislation Atlas Investments
BRIEF published on 03/18/2026 at 18:05, 7 months 18 days ago Oxurion receives a transparency notification from Atlas Special Opportunities Pharmaceutical Financial Transparency Atlas Special Opportunities Oxurion Digital Investments
Published on 11/06/2026 at 00:53, 1 hour 38 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 1 hour 46 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 2 hours 36 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/05/2026 at 23:20, 3 hours 11 minutes ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/06/2026 at 00:05, 2 hours 26 minutes ago RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 4 hours 26 minutes ago Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 5 hours 53 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 5 hours 54 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 6 hours 45 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 18:21, 8 hours 10 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 8 hours 10 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
